Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The Oxford Parkinson's Disease Centre received the award for their contribution to the Critical Path for Parkinson’s initiative

Created in partnership with Parkinson's UK, the Critical Path for Parkinson's Consortium (CPP) was launched in 2015. It is a global collaboration that facilitates collaboration among scientists from the bio-pharmaceutical industry, academic institutions, government agencies, and patient-advocacy associations. It fosters consensus and data-driven research to increase efficiency, safety, and speed in developing new therapies.

The Oxford Parkinson's Disease Centre is jointly led by Professor Michele Hu in our Department, and Professor Richard Wade-Martins from the Department of Physiology, Anatomy & Genetics.

Similar stories

John Jacob wins clinical academic research partnership for brain cancer project

The Medical Research Council awarded Dr John Jacob upwards of £200,000 to fund a project on brain cancer modelling.

New consortium to uncover mechanisms of neuropathic pain

Professor David Bennett is leading a new national research consortium to investigate neuropathic pain.

NDCN Thomas Willis Day Prize Winners

Our annual Thomas Willis Day celebrates the work of our Department over the previous year.

Capturing immune cells that colonise the brain to prevent disease progression in multiple sclerosis

Researchers have revealed a disease-causing population of immune cells, which travel to the brain in patients with multiple sclerosis. They demonstrate how to trap these cells in the blood, which means they can be targeted to prevent disease progression.